Anesthesia & Pain Medicine
Our team understands the unique ethical considerations associated with conducting trials in patients with acute or chronic pain.
In the realm of anesthesia and pain medicine, we have deep expertise in the design and execution of trials for:
- Novel analgesics
- Anesthetics
- Adjunct therapies
We know the importance of objective and subjective pain assessments, safety measures related to sedation and anesthesia, and biomarkers of pain and inflammation.
Pain points associated with clinical trials in anesthesia and pain medicine
- Patient Recruitment and Retention: Finding suitable patients who meet the specific criteria for anesthesia and pain medicine trials can be challenging. Additionally, ensuring that these patients remain engaged and complete the study often poses significant hurdles.
- Standardization of Pain Measurement: Pain is subjective, and its measurement can vary between patients and evaluators. This makes consistent assessment difficult.
- Placebo Effects and Blinding: Given the subjective nature of pain, placebo effects can be profound in pain medicine trials. Ensuring effective blinding can be challenging.
- Safety Monitoring: As anesthesia and pain medications often have systemic effects, monitoring for adverse events and ensuring patient safety is critical.
How iNGENū addresses these pain points
- Patient Recruitment and Retention: iNGENū leverages advanced patient databases to identify suitable candidates rapidly. We also ensure continuous engagement and use patient-centric approaches, such as flexible scheduling and remote monitoring, to maximize retention.
- Standardization of Pain Measurement: We implement standardized and validated pain assessment tools. We also offer training sessions for clinical staff on the consistent use and interpretation of these tools, ensuring uniformity across all trial sites.
- Placebo Effects and Blinding: iNGENū designs trials with robust blinding methodologies, minimizing potential biases. We also use advanced statistical techniques to account for and analyze placebo responses, ensuring the integrity of the trial results.
- Safety Monitoring: We employ state-of-the-art safety monitoring systems and protocols. Our dedicated safety board reviews data in real-time, ensuring rapid response to any adverse events. With a focus on patient well-being, we prioritize transparent communication with all stakeholders about potential risks and safety measures.